This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More
News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More
Shionogi has announced plans to acquire IntraBio, a biopharmaceutical company developing therapies for neurodegenerative diseases, for $2 billion. The transaction will add Aqneursa (levacetylleucine) and IntraBio’s capabilities in the rare disease area to Shionogi’s growing portfolio. Aqneursa was approved by the FDA in September 2024… Read More
The Association of the British Pharmaceutical Industry (ABPI) has launched its first Youth Advisory Council, a new advisory body made up of young people aged 16 to 19 from across the UK, tasked with challenging and shaping how the pharmaceutical industry inspires, engages and communicates with the next generation. Read More
Eli Lilly and Gate Bioscience have expanded their collaboration to discover, develop, and commercialise molecular gate therapeutics. The expanded collaboration adds one target, with the opportunity to add a second target, to the companies’ existing work. The programmes leverage Gate’s Molecular Gate drug discovery engine… Read More
MimiVax and Roswell Park Comprehensive Cancer Center have announced results from the SURVIVE Phase IIb clinical trial evaluating novel cancer vaccine, SurVaxM, in patients with newly diagnosed glioblastoma. The data reflect the first reportable results from the fully enrolled clinical trial, which has been underway since 2022… Read More
Ahead of the Budget, UK life sciences groups have called on the Chancellor to prioritise investment in new medicines. The UK government has set out bold targets for the UK’s life sciences sector. By 2030, it wants the UK to lead Europe in commercial research and development… Read More
DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development. This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII… Read More
Biopharma dealmaking confidence is strengthening, a new survey has revealed, but access to capital remains the defining challenge. BIO-Europe’s Biopharma C-Suite Agenda Survey 2026 surveyed 81 senior biopharma executives, including 50 CEOs. The survey results demonstrate that 75% expect partnering and M&A appetite to increase… Read More
Peptide therapeutics, while one of the fastest growing drug modalities, are challenging to formulate, due to heir conformational flexibility, propensity for aggregation and fibrillation, and sensitivity to pH. In this Application Note from Nanotemper, learn how to: Simultaneously assess thermal and colloidal stability to reveal early self-association propensity Compare finished-product… Read More
Cancer Research UK has signed an agreement with ORIC Pharmaceuticals to advance ORIC-259, a potential first-in-class CIP2A-targeted therapy, into clinical development. Under the agreement, Cancer Research UK’s Centre for Drug Development (CDD) will fully fund, sponsor, design and execute a Phase I/II clinical trial of ORIC-259, including… Read More
Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More
o2h co-discovery has announced that the Cambridge and London Life Sciences Showcase will return for its second edition during JP Morgan Healthcare Week 2027 in San Francisco. The event provides emerging companies with an international platform to present their science, innovation and growth opportunities directly to investors,… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
Roswell Park Comprehensive Cancer Center and Generate Biomedicines have dosed the first patient in a first-in-human clinical trial evaluating GB-5267, an autologous IL‑18–armoured CAR T-cell therapy. The therapy is designed to overcome key barriers that have limited the success of cellular therapies in solid tumours. … Read More
The Nobel Assembly at Karolinska Institutet has awarded the 2026 Nobel Prize in Physiology or Medicine to three scientists “for their discoveries concerning light-gated ion channels and optogenetics”. It was jointly presented to Karl Deisseroth, The Howard Hughes Medical Institute and Stanford University, USA; Peter Hegemann, Humboldt… Read More
